These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 27593880

  • 1. Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy.
    Park H, Ko SH, Lee JM, Park JH, Choi YH.
    Yonsei Med J; 2016 Nov; 57(6):1494-9. PubMed ID: 27593880
    [Abstract] [Full Text] [Related]

  • 2. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth].
    Koirala K, Wan YL, Liu YC, Wang X, Cui W, Wang CL, Chen HN, Wang HY, Zhu J.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug 18; 38(4):385-8. PubMed ID: 16892143
    [Abstract] [Full Text] [Related]

  • 3. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells.
    Hosokawa M, Kudo M, Maeda H, Kohno H, Tanaka T, Miyashita K.
    Biochim Biophys Acta; 2004 Nov 18; 1675(1-3):113-9. PubMed ID: 15535974
    [Abstract] [Full Text] [Related]

  • 4. Troglitazone and 9cis,11trans,13trans-conjugated linolenic acid: comparison of their antiproliferative and apoptosis-inducing effects on different colon cancer cell lines.
    Yasui Y, Hosokawa M, Kohno H, Tanaka T, Miyashita K.
    Chemotherapy; 2006 Nov 18; 52(5):220-5. PubMed ID: 16899971
    [Abstract] [Full Text] [Related]

  • 5. Effect of ligand troglitazone on peroxisome proliferator-activated receptor gamma expression and cellular growth in human colon cancer cells.
    Ming M, Yu JP, Meng XZ, Zhou YH, Yu HG, Luo HS.
    World J Gastroenterol; 2006 Dec 07; 12(45):7263-70. PubMed ID: 17143939
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K.
    Cancer; 2002 Nov 15; 95(10):2243-51. PubMed ID: 12412180
    [Abstract] [Full Text] [Related]

  • 7. Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells.
    Zhou YM, Wen YH, Kang XY, Qian HH, Yang JM, Yin ZF.
    World J Gastroenterol; 2008 Apr 14; 14(14):2168-73. PubMed ID: 18407589
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer.
    Qiao L, Dai Y, Gu Q, Chan KW, Zou B, Ma J, Wang J, Lan HY, Wong BC.
    Mol Cancer Ther; 2008 Jul 14; 7(7):2203-11. PubMed ID: 18645029
    [Abstract] [Full Text] [Related]

  • 9. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN, Lee YR, Noh EM, Lee KS, Kim JS, Song EK, Han MK, Lee YC, Kwon KB, Lee SJ, Youn HJ, Jung SH.
    Cell Biol Int; 2008 Aug 14; 32(8):906-12. PubMed ID: 18474441
    [Abstract] [Full Text] [Related]

  • 10. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W, Röcken C, Malfertheiner P, Farrell GC.
    Hepatology; 2006 Jan 14; 43(1):134-43. PubMed ID: 16374840
    [Abstract] [Full Text] [Related]

  • 11. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
    Toyoda M, Takagi H, Horiguchi N, Kakizaki S, Sato K, Takayama H, Mori M.
    Gut; 2002 Apr 14; 50(4):563-7. PubMed ID: 11889080
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.
    Hamaguchi N, Hamada H, Miyoshi S, Irifune K, Ito R, Miyazaki T, Higaki J.
    Cancer Sci; 2010 Sep 14; 101(9):1955-64. PubMed ID: 20608936
    [Abstract] [Full Text] [Related]

  • 13. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
    Ban JO, Kwak DH, Oh JH, Park EJ, Cho MC, Song HS, Song MJ, Han SB, Moon DC, Kang KW, Hong JT.
    Chem Biol Interact; 2010 Oct 06; 188(1):75-85. PubMed ID: 20540935
    [Abstract] [Full Text] [Related]

  • 14. Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.
    Kato M, Kusumi T, Tsuchida S, Tanaka M, Sasaki M, Kudo H.
    J Cancer Res Clin Oncol; 2004 Feb 06; 130(2):73-9. PubMed ID: 14634802
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
    Fujita M, Hasegawa A, Yamamori M, Okamura N.
    J Exp Clin Cancer Res; 2017 Jul 03; 36(1):91. PubMed ID: 28673319
    [Abstract] [Full Text] [Related]

  • 16. Troglitazone induced apoptosis via PPARγ activated POX-induced ROS formation in HT29 cells.
    Wang J, Lv X, Shi J, Hu X, DU Y.
    Biomed Environ Sci; 2011 Aug 03; 24(4):391-9. PubMed ID: 22108328
    [Abstract] [Full Text] [Related]

  • 17. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
    Akinyeke TO, Stewart LV.
    Cancer Biol Ther; 2011 Jun 15; 11(12):1046-58. PubMed ID: 21525782
    [Abstract] [Full Text] [Related]

  • 18. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
    Ban JO, Oh JH, Son SM, Won D, Song HS, Han SB, Moon DC, Kang KW, Song MJ, Hong JT.
    Cancer Biol Ther; 2011 Aug 15; 12(4):288-96. PubMed ID: 21613824
    [Abstract] [Full Text] [Related]

  • 19. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
    Qiao L, Dai Y, Gu Q, Chan KW, Ma J, Lan HY, Zou B, Rocken C, Ebert MP, Wong BC.
    Cancer Lett; 2008 Sep 18; 268(2):260-71. PubMed ID: 18477501
    [Abstract] [Full Text] [Related]

  • 20. PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux.
    Nazim UM, Moon JH, Lee YJ, Seol JW, Park SY.
    Oncotarget; 2017 Apr 18; 8(16):26819-26831. PubMed ID: 28460464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.